Caricamento...
P15.01 WOUND HEALING COMPLICATIONS IN BRAIN TUMOR PATIENTS ON BEVACIZUMAB
Bevacizumab (BV) is a monoclonal antibody against vascular endothelial growth factor A (VEGF-A) and is commonly used for treatment of recurrent glioblastoma (GBM). Wound healing problems are a well-established adverse event, which may be compounded by the concomitant use of corticosteroids. Here, we...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4185639/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.280 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|